IL17A and obesity due to melanocortin 4 receptor deficiency: The most highly enriched pathways were “insulin resistance” and “IL-17 signaling pathway.” Notably, we also identified mRNAs involved in the regulation of these pathways, which may provide targets for Sal B as a potential drug to prevent HFD-induced obesity (Table 3).